Table 3.

Overview of the demographic and clinical dataset

Basics	Sample Size	1796
	Patients Consented	549
	Number of variables	13
	Involvement in clinical trial	Yes /No
Demographics	Demographics	Age at diagnosis Ethnicity Postcode
Prostate Cancer Characteristics	Diagnostic markers	PSA Gleason score TNM stage
Treatment	Treatment type	Surgery, Active monitoring, Anti-cancer drug regimen (hormone therapy), Anti-cancer drug regimen (cytotoxic chemotherapy), Brachytherapy, Specialist palliative care
	Comorbidities	All, Previous/other cancers, Cardiovascular disease, HIV or infectious disease, Hyperlipidaemia and hypercholesterolemia, Diabetes, Psychological
	Medication	Total number of medications, Erectile dysfunction medication
	Outcome	Disease stable, Discharged to GP, Treatment discharged to GP, Discharged to different hospital, Progression, Progression to metastasis, Recurrence, Death, Awaiting treatment, Refused further treatment, Treated privately, Lost to follow up

The following abbreviations have been used: Prostate Specific Antigen (PSA), Human Immuno-Deficiency Virus (HIV) and General Practitioner (GP)